No matter where you look, CBD is paving a path for a new era of human health and wellness, but there still seems to be a lot of confusion floating around about what this medical marvel really is. Today, we’re going to walk you through everything you need to know about this burgeoning sector.
Whether you’ve seen it in your health food store, on local billboards, or have simply read about it in the news, the buzz surrounding CBD (cannabidiol) just keeps getting louder.
People are drinking it in tea, taking them with their daily supplements, even smearing it on their skin with creams, oils, and analgesics to combat everything from chronic pain to anxiety.
Fact is, no matter where you look, CBD is paving a path for a new era of human health and wellness.
That’s why, here at the National Institute for Cannabis Investors, not only do we know that this medical marvel will outshine all others in 2019 – it also represents one of the hottest, most lucrative investing opportunities in the industry.
Right now, our analysts predict this market will go gangbusters – swelling over 3,667% over the next five years alone.
Meaning that there could be hundreds of billions or even trillions of dollars in profits from CBD-based treatments.
In fact, my paid-up subscribers have already started to see profits roll in from one of the leading CBD players in the game.
Yet, despite the fact that CBD is one of the hottest cannabis sectors on the planet right now, there still seems to be a lot of confusion floating around about what this medical marvel really is.
That’s why today, we’re going to walk you through all of the details you need to know about this burgeoning sector.
What Is CBD?
One of the first misconceptions surrounding CBD is that it will have the same effects as its well-known cousin, Tetrahydrocannabinol (THC) – the infamous molecule that gets you “high.”
However, the truth is, while these two might in fact both be active compounds found in the Cannabis sativa plant, they have very little in common.
Unlike THC, cannabidiol is non-psychoactive, meaning you get all of the medical benefits without getting a “high” or euphoric feeling.
More importantly, it’s a compound some mammals – including humans – produce naturally.
Your body has what’s called an endocannabinoid system: a complex network that helps regulate your sleep schedule, mood, immune system, pain, and appetite, just to name a few.
Over the years, the team here at NICI has noticed a trend. If you want to beat Wall Street, if you want to trade like America’s elite, you need to have this invaluable tool that helps pinpoint the most lucrative profit opportunities in the game in your arsenal. And if you click here we can show you how you can get this powerful investing tool at your fingertips.
When CBD is consumed, it can actually enhance your natural endocannabinoid system to help regulate these systems.
It’s CBD’s direct link to the endocannabinoid system that enticed the medical community to study the molecule in the first place.
So far researchers have found that it can effectively treat a number of conditions, including chronic pain, inflammation, insomnia, multiple sclerosis, PTSD, and epilepsy. It has even been shown to have anti-depressant and anti-anxiety capabilities.
And that’s just a small taste of the ailments CBD has been proven to help treat.
But how exactly does it work?
Let’s take a few minutes to break it down.
Cannabinoid Receptors Built Right into Our Body
As I mentioned, the human body can also produce cannabinoids as part of the endocannabinoid system.
In addition to producing cannabinoids, this system also includes two types of receptors found in cells throughout our bodies. One is called the CB1 receptor, and the other is called the CB2 receptor.
CB1 receptors are primarily found in the central nervous system, which includes the brain, while CB2 receptors are mostly in they lymphatic system and immune cells.
THC binds with CB1 receptors, and – since those receptors are in the brain – it creates a psychoactive response and you get high.
But CBD binds with CB2 receptors, which are not in the brain, so it doesn’t create a high.
This tailored design makes CBD a very effective remedy for a host of conditions. Because these are found primarily in the lymphatic system and immune cells, they help with health problems due to overactive immune responses, pain, inflammation, and many others.
And, what’s more, it doesn’t have to be cooked up in a laboratory.
It’s just pulled out of the plant and transformed into a variety of forms – meaning people can tailor their method of use to their specific need.
Right now, the most common forms are…
- Oils and tinctures – typically applied via a dropper under the tongue for rapid pain relief.
- Creams and lotions – CBD-infused topical treatments like this are used to treat muscle and joint pain.
- Edibles – CBD gummies are one of the most popular ways to consume CBD.
- Capsules – CBD in capsule or pill form has been the go-to consumption method for seizure and digestive disorders. In fact, the U.S. Food and Drug Administration recently approved its first high-potency CBD drug to treat epilepsy.
- Vaping – inhaling vaporized CBD has proven to be the fastest way to experience the effects of this medical breakthrough. Compounds that are inhaled are absorbed directly from the lungs into the bloodstream.
And it’s the simplicity – and unpatentability – of this powerful natural remedy that is putting the pharmaceutical industry on the defensive.
CBD’s Path to a Billion-Dollar Market
As I told you about a couple of months ago, Pharma knows this is a big threat to its traditional profit model.
Which means that not only will health and wellness companies selling the best CBD products dominate the $80 billion nutraceuticals market, but they could also cut significantly into the $1 trillion market for traditional pharmaceutical products.
Until recently, scientists had been unable to go “all-in” on studying the medical properties of CBD thanks to the murky legality surrounding marijuana.
However, thanks to the recent passage of the 2018 Farm Bill, which removed CBD and hemp products from the Controlled Substances Act entirely, this niche market is about to open in a big way.
In fact, the CBD market could triple from $600 million to nearly $1.8 billion, with more growth to follow, thanks to this landmark bill.
Frankly, ours isn’t even the most optimistic estimate out there. One analyst estimates that the CBD market will grow to nearly 10 times its current size in just one year thanks to this singular market move.
With the murky legal cloud gone, expect to see a flurry of companies, both in cannabis and outside markets, to be making large investments into the CBD space while the FDA’s process is under way.
To put it simply, a massive wealth wave is headed for the CBD market. A seismic change from which subscribers to Cannabis Investor’s Report are well-positioned to profit.
Frankly, this is going to be one of the great storylines unfolding in cannabis today, and in 2019, so you can rest assured that we’ll be keeping close tabs on this evolving market.
Thanks for being an important part of the National Institute for Cannabis Investors,
Executive Director, National Institute for Cannabis Investors
P.S. One of the most exciting aspects of the future $24.5 billion cannabis market is there will be a flurry of marijuana IPOs. Our estimates show each of these companies is capable of generating between $500 million and $3 billion for investors when they go public. That’s a potential $12 billion in new wealth in a matter of weeks. And today, we want to show you how to become millionaires from this little-understood investing phenomenon. Just click here to learn more.